Outcomes after PD-103 versus I-125 for low dose rate prostate brachytherapy monotherapy: An international, multi-institutional study-Reference-Cited by-同舟云学术

Outcomes after PD-103 versus I-125 for low dose rate prostate brachytherapy monotherapy: An international, multi-institutional study

Published:2023-06 Issue: Volume:183 Page:109599
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Tang Chad,Sanders Jeremiah,Thames Howard,Swanson David M,Crook Juanita M.,Bruno Teresa,Blanchard Pierre,Ciezki Jay,Keyes Mira,Song Daniel,Singh Tanmay,Merrick Gregory,Stock Richard,Sullivan Francis J.,Mok Henry,Millar Jeremy,Frank Steven J.

Funder

Cancer Prevention and Research Institute of Texas

University of Texas MD Anderson Cancer Center

National Institutes of Health

National Cancer Institute

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference20 articles.

1. An arm and a leg: the rising cost of cancer drugs and impact on access;Leighl;Am Soc Clin Oncol Educ Book,2021

2. Economic burden of cancer across the European Union: a population-based cost analysis;Luengo-Fernandez;Lancet Oncol,2013

3. I-125 versus Pd-103 for low-risk prostate cancer: morbidity outcomes from a prospective randomized multicenter trial;Wallner;Cancer J,2002

4. Multi-institutional analysis of long-term outcome for stages T1–T2 prostate cancer treated with permanent seed implantation;Zelefsky;Int J Radiat Oncol Biol Phys,2007

5. Isotope selection for patients undergoing prostate brachytherapy;Cha;Int J Radiat Oncol Biol Phys,1999

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The low‐LET radiation contribution to the tumor dose in diffusing alpha‐emitters radiation therapy;Medical Physics;2023-12-14